Optimized 5-HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction

Roy, S. M., Acquarone, E., Argyrousi, E. K., Zhang, H., Staniszewski, A., Inoue, A., Ziarek, J. J., Arancio, O., & Watterson, D. M. (2025). Optimized 5‐HT2b inhibitors for neuropsychiatric syndromes with cognitive dysfunction. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 11(1). Portico. https://doi.org/10.1002/trc2.70073
Authors:
Saktimayee M Roy
Erica Acquarone
Elentina K Argyrousi
Hong Zhang
Agnieszka Staniszewski
Asuka Inoue
Joshua J Ziarek
Ottavio Arancio
D Martin Watterson
Affiliated Authors:
Ottavio Arancio
Columbia Affiliation:
Author Keywords:
5-ht2b
aggression
alzheimer's disease
anxiety
atypical neurotherapeutics
cognitive dysfunction
depression
g-protein-coupled receptor serotonin receptors
humans
irritability
memory
mental health
risperidone
synaptic plasticity
tauopathies
5-ht<sub>2b</sub>
g-protein–coupled receptor serotonin receptors
5‐ht2b
g‐protein–coupled receptor serotonin receptors
elink
Publication Type:
Article
Unique ID:
10.1002/trc2.70073
PMID:
40151398
DOI:
10.1002/trc2.70073
Journal:
Alzheimer's and Dementia: Translational Research and Clinical Interventions
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: